Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Check which passive funds beat the market in 2024 retirement planning and what factors contributed to their outperformance.
28,482 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
As factories re-shore production in 2026, three ETFs track the trend with different tilts. Here is how AIRR, PAVE, an...
As pay-TV declines, Comcast may lean on first-party data to power targeted streaming ads. This article breaks down ho...
Bloom Energy and Plug Power are leading the move toward cleaner power. This guide breaks down their business models, ...
Red Cat stock crashed today after the company announced a large share offering to raise capital. This piece breaks do...
Lawmakers push a federal framework for digital assets to reduce regulatory fragmentation. The Digital Asset Market Cl...
Crypto millionaire growth accelerates in 2026 as ETFs lure institutions and major tokens attract capital. Analysts we...
In late June 2026, XRP and XLM are both testing breakout attempts after weeks of consolidation. Neither has confirmed...
In 2026, some markets will heat up while others cool down. This guide outlines the 10 markets where prices will rise ...
Circle Internet Group sparked a strong move in the market as investors welcomed a robust quarterly report. This artic...
A broader AI software sell-off created a rare opportunity for long-term investors. Here are three blue-chip options t...
As mega-cap tech pours capital into AI, investors seek signs of durable returns. This piece analyzes which firms stan...